Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.
- Author
- American Medical Association
- Published
- Tue 10 Mar 2015
- Episode Link
- http://dx.doi.org/10.1001/jama.2014.11623
Editor's Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue
